We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Menarini Introduces PRIME MDx All-in-One Molecular Diagnostics Solution

By LabMedica International staff writers
Posted on 23 May 2023
Print article
Image: PRIME MDx all-in-one, sample-to-result, fully automated solution (Photo courtesy of Menarini)
Image: PRIME MDx all-in-one, sample-to-result, fully automated solution (Photo courtesy of Menarini)

Menarini Diagnostics (Florence, Italy) is presenting its range of innovative professional diagnostics solutions in the field of molecular diagnostics, autoimmunity testing, hemoglobin analysis, and immunoassay testing at EuroMedLab Rome 2023.

The main highlight at Menarini's booth during this industry event is the brand new PRIME MDx all-in-one solution. This fully automated sample-to-result system is specifically designed to streamline laboratory workflows for real-time PCR diagnostic assays, offering exceptional efficiency, flexibility, and ease of use. With its automation and guided instrument setup, PRIME MDx minimizes manual intervention and ensures full sample traceability. Dedicated software enables automatic result generation and interpretation, leading to high-quality results, workflow standardization, and improved laboratory efficiency. The continuous workflow feature allows users to initiate a new loading process (extraction/setup) while a previous PCR is still running. PRIME MDx offers the flexibility to manage runs with various extraction reagent formats (prefilled or standard) and seamlessly integrates with existing IT infrastructure.

At the 2023 WordLab-EuroMedLab Congress, Menarini is also presenting the Zenit range of high-throughput innovations. This includes the Zenit PRIME random access chemiluminescence analyzer, catering to the autoimmunity laboratory's needs with its comprehensive panel of reagents and advanced features. The walk-away system boasts a throughput of up to 120 tests/hour, with continuous loading and random access to samples, specific and common reagents, and consumables, enabling efficient operation within an 8-hour timeframe (1000 tests).

In addition, Menarini is showcasing the winning combination of Zenit flow and Zenit fast in IIF (Indirect Immunofluorescence) slide processing and scanning. The Zenit flow automated IIF slide processor performs all necessary steps, from sample dilution to coverslip mounting, resulting in improved standardization and a flexible, optimized workflow within the laboratory. The Zenit flow is complimented by the Zenit fast automated diagnostics system for the acquisition, analysis, and storage of IFA (Immunofluorescence Assay) slides. It provides laboratories with an efficient solution to enhance the management of IFA tests, standardize the validation procedure, and reduce intra- and inter-laboratory variability. Some noteworthy features of Zenit fast include image autofocusing technology, whole-well scanning capability, software algorithms for IFA detection and pattern recognition, run-time efficiency, recognition of various ANA (Antinuclear Antibody) IFA patterns, and the ability to analyze different IFA substrates.

Related Links:
Menarini Diagnostics 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more